📊 MODD Key Takeaways
Is Modular Medical, Inc. (MODD) a Good Investment?
Modular Medical faces an existential cash crisis with operating cash burn of $23.8M annually and only $6.9M in cash reserves (approximately 3 months runway). The combination of zero gross profit on $16M revenue, -$28.2M net loss, and -$27.7M free cash flow indicates fundamental operational failure or severe data quality issues. Without immediate capital infusion or dramatic operational restructuring, the company faces imminent solvency risk.
Modular Medical remains effectively pre-revenue, making the reported revenue growth rate economically meaningless while operating losses and cash burn remain extreme. Although liquidity is currently adequate and the balance sheet carries little financial leverage, the $27.68 million free-cash-flow deficit substantially exceeds available cash, creating significant financing and dilution risk.
Modular Medical, Inc. Key Strengths (MODD)
- Strong liquidity position with 4.03x current ratio providing short-term cushion
- Zero long-term debt eliminates leverage risk and provides flexibility for restructuring
- Operates in medical devices sector with potential for high-margin products if operational issues resolved
- Strong 4.03x current and quick ratios
- No reported long-term debt and a 0.00x debt-to-equity ratio
- Positive stockholders' equity of $12.96 million
MODD Stock Risks: Modular Medical, Inc. Investment Risks
- Critical cash runway of <3 months at current burn rate of -$27.7M FCF annually
- Zero gross profit on $16M revenue indicates products sold at loss or fundamental business model failure
- Massive operating losses (-$27.6M) with no clear path to profitability suggest unsustainable cost structure
- Negative ROE (-217.9%) and ROA (-190.4%) indicate severe shareholder value destruction
- Likely requires immediate capital raise which will cause significant equity dilution
- Negligible revenue and no gross profit indicate an unproven commercial model
- Operating loss of $27.56 million and net loss of $28.24 million reflect severe unprofitability
- Free-cash-flow burn of $27.68 million versus $6.94 million of cash implies substantial near-term capital needs
Key Metrics to Watch
- Operating cash flow trend and monthly burn rate (current -$23.8M is unsustainable)
- Gross profit reconciliation - zero margin requires investigation for accounting or operational issues
- Cash balance decline rate and timeline to funding event
- Revenue quality and product-level gross margins breakdown
- Revenue growth accompanied by positive gross profit
- Operating cash burn and remaining cash runway
Modular Medical, Inc. (MODD) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 4.03x current ratio provides a solid financial cushion.
MODD Profit Margin, ROE & Profitability Analysis
MODD vs Healthcare Sector: How Modular Medical, Inc. Compares
How Modular Medical, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Modular Medical, Inc. Stock Overvalued? MODD Valuation Analysis 2026
Based on fundamental analysis, Modular Medical, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Modular Medical, Inc. Balance Sheet: MODD Debt, Cash & Liquidity
MODD Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Modular Medical, Inc.'s revenue has declined by 100% over the 5-year period, indicating business contraction. The most recent EPS of $-15.26 indicates the company is currently unprofitable.
MODD Revenue Growth, EPS Growth & YoY Performance
MODD Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2019 | N/A | -$258.8K | N/A |
| Q2 2019 | N/A | -$176.0K | N/A |
| Q1 2019 | N/A | -$38.7K | N/A |
| Q3 2018 | N/A | -$6.4K | N/A |
| Q2 2018 | N/A | -$1.1K | N/A |
| Q3 2017 | N/A | -$6.7K | N/A |
| Q2 2017 | N/A | -$6.9K | N/A |
| Q1 2017 | N/A | -$11.0K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Modular Medical, Inc. Dividends, Buybacks & Capital Allocation
MODD SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Modular Medical, Inc. (CIK: 0001074871)
📋 Recent SEC Filings
❓ Frequently Asked Questions about MODD
What is the AI rating for MODD?
Modular Medical, Inc. (MODD) has a Combined AI Grade of D from Claude (D) and ChatGPT (D) with 91% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are MODD's key strengths?
Claude: Strong liquidity position with 4.03x current ratio providing short-term cushion. Zero long-term debt eliminates leverage risk and provides flexibility for restructuring. ChatGPT: Strong 4.03x current and quick ratios. No reported long-term debt and a 0.00x debt-to-equity ratio.
What are the risks of investing in MODD?
Claude: Critical cash runway of <3 months at current burn rate of -$27.7M FCF annually. Zero gross profit on $16M revenue indicates products sold at loss or fundamental business model failure. ChatGPT: Negligible revenue and no gross profit indicate an unproven commercial model. Operating loss of $27.56 million and net loss of $28.24 million reflect severe unprofitability.
What is MODD's revenue and growth?
Modular Medical, Inc. reported revenue of $16.0.
Does MODD pay dividends?
Modular Medical, Inc. does not currently pay dividends.
Where can I find MODD SEC filings?
Official SEC filings for Modular Medical, Inc. (CIK: 0001074871) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is MODD's EPS?
Modular Medical, Inc. has a diluted EPS of $-12.36.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is MODD's fundamental grade?
Based on our AI fundamental analysis in August 2026, Modular Medical, Inc. has a D grade with 91% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is MODD stock overvalued or undervalued?
Valuation metrics for MODD: ROE of -217.9% (sector avg: 15%), net margin of -176,512,500.0% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is MODD's AI grade for 2026?
Our dual AI analysis gives Modular Medical, Inc. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is MODD's free cash flow?
Modular Medical, Inc.'s operating cash flow is $-23.8M, with capital expenditures of $3.9M. FCF margin is -173,031,250.0%.
How does MODD compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -176,512,500.0% (avg: 12%), ROE -217.9% (avg: 15%), current ratio 4.03 (avg: 2).